Clinical Trials Browser

Phase 2/3 × Granulocyte Colony-Stimulating Factor × Plasma cell × Clear all

NCT00177047 2021-11-09

Autologous Transplant for Multiple Myeloma

Phase 2/3 Completed

363 enrolled 25 charts

Multiple Myeloma